Sphere Entertainment Appoints Robert Langer as CFO
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.41 USD | -0.04% |
|
+3.15% | +17.58% |
02-06 | Updated Msg Networks Statement On Altice Dispute | RE |
02-04 | Sphere Entertainment Co. Appoints Glenn Derry as Executive Vice President of MSG Ventures | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationFounder of 40 different companies, among them: Moderna, Inc., Momenta Pharmaceuticals, Inc. and Seer, Inc. (California), Robert S. Langer is an entrepreneur is Professor at Massachusetts Institute of Technology, Specialists at The Water Initiative LLC and Professor at David H. Koch Institute for Integrative Cancer Research and on the board of 31 other companies. In the past he was Director at Combinent BioMedical Systems, Inc. (he founded the company in 2009), Board Advisor at Celero Systems, Inc. (he founded the company), Chairman-Science Board at US Food & Drug Administration, Member of National Academy of Sciences, Member of National Academy of Engineering, Member of Institute of Medicine, Director at Momenta Pharmaceuticals, Inc., Director at Pervasis Therapeutics, Inc., Director at DNIB Unwind, Inc., Director at Semprus BioSciences Corp., Director at Selecta Biosciences, Inc., Director at Kala Pharmaceuticals, Inc., Director at SQZ Biotechnologies Co., Director at Microchips Biotech, Inc., Director at T2 Biosystems, Inc., Director at Lyra Therapeutics, Inc., Director at Tarveda Therapeutics, Inc. and Director at Sigilon Therapeutics, Inc. Robert S. Langer received an undergraduate degree from Cornell University and a doctorate from Massachusetts Institute of Technology.
View full profile